Biotech News

PureTech Health plc – Half-Year Report

PureTech Health (PRTC)PureTech Health2026-09-22 06:00 ESTClinical readout

RNS Number: 6717V PureTech Health PLC 22 September 2026 22 September 2026 PureTech Health plc - Half-Year Report Delivered significant progress across the portfolio, including Seaport's Nasdaq IPO, Celea's financing and Phase 3 trial initiation, and Gallop's positive Phase 1b data, successful

PureTech Health

Founded-Entity Model PureTech Health creates and advances biotechnology companies around internally identified scientific concepts. Rather than operating as a conventional single-pipeline developer, it retains ownership interests and economic rights across a portfolio of independently financed founded entities. Celea Therapeutics Celea...

Recent company news

PRTCPureTech Health2026-10-07 17:00 EST

PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance

PRTCPureTech Health2026-09-22 06:00 EST